PetMed Express (NASDAQ:PETS) and Guardian Pharmacy Services (NYSE:GRDN) Head to Head Contrast

PetMed Express (NASDAQ:PETSGet Free Report) and Guardian Pharmacy Services (NYSE:GRDNGet Free Report) are both small-cap retail/wholesale companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Earnings and Valuation

This table compares PetMed Express and Guardian Pharmacy Services”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PetMed Express $259.34 million 0.39 -$7.46 million ($0.06) -82.33
Guardian Pharmacy Services N/A N/A N/A N/A N/A

Guardian Pharmacy Services has lower revenue, but higher earnings than PetMed Express.

Institutional & Insider Ownership

73.3% of PetMed Express shares are held by institutional investors. 1.1% of PetMed Express shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares PetMed Express and Guardian Pharmacy Services’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PetMed Express -0.37% -1.00% -0.60%
Guardian Pharmacy Services N/A N/A N/A

Analyst Ratings

This is a breakdown of recent recommendations for PetMed Express and Guardian Pharmacy Services, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetMed Express 1 1 0 0 1.50
Guardian Pharmacy Services 0 0 3 0 3.00

PetMed Express currently has a consensus target price of $3.50, indicating a potential downside of 29.15%. Guardian Pharmacy Services has a consensus target price of $22.00, indicating a potential upside of 2.31%. Given Guardian Pharmacy Services’ stronger consensus rating and higher possible upside, analysts plainly believe Guardian Pharmacy Services is more favorable than PetMed Express.

Summary

Guardian Pharmacy Services beats PetMed Express on 6 of the 9 factors compared between the two stocks.

About PetMed Express

(Get Free Report)

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.